ASTER: Interest of Direct Aspiration First Pass Technique (ADAPT) for Thrombectomy Revascularisation of Large Vessel Occlusion in Acute Ischaemic Stroke

Sponsor
Fondation Ophtalmologique Adolphe de Rothschild (Other)
Overall Status
Completed
CT.gov ID
NCT02523261
Collaborator
(none)
381
8
2
15.8
47.6
3

Study Details

Study Description

Brief Summary

Mechanical thrombectomy (TM) is now validated through 4 randomized controlled trials of high scientific level as the reference treatment of cerebral infarction associated with proximal cerebral occlusion (MR CLEAN, ESCAPE 2014, 2015). These studies have shown for the first time a major decrease (-35%) of disability related to severe cerebral infarction and reduction in mortality. These studies only used thrombectomy devices called stent retriever for obtaining recanalization rates ranging from 58-72% for the 2 largest studies (MR CLEAN, ESCAPE 2014, 2015). This criterion "recanalization" is important because it largely determines the functional prognosis of patients with severe cerebral infarction (Khatri, 2014).

These results are exciting but we can do even better. Indeed, already new thrombectomy devices are available with a special interest for ADAPT (A Direct Aspiration First Pass Technic). This distal suction system, with a high level of endovascular navigability, provides high recanalization rates (> 90%), low morbidity, with a synergistic effect with stent retriever (Turk A, Kowoll 2014 and 2015). To date, these technic (ADAPT) has never been assessed in a randomized controlled trial.

We have previously conducted a comparative observational study between two recanalization strategies by thrombectomy using first-line ADAPT or the most widely used stent retriever. The interventional neuroradiologist could, in case of recanalization failure with the Solitaire system, used another thrombectomy material left to the operator's choice. 244 consecutive patients on two centers (Rothschild Foundation, and Foch Hospital, France) admitted for a cerebral infarction associated with proximal occlusion were included. This is so far the largest series of patients with ADAPT system. The complete recanalization rate was 84% with ADAPT versus 68% with stent retriever (P = 0.006). Unpublished data, Oral presentation at the European Stroke Organization, April 2015). Our research aims to show that a first line strategy of recanalization by thrombectomy using a distal suction system (ADAPT) is superior that the use of a stent retriever.

Condition or Disease Intervention/Treatment Phase
  • Procedure: direct aspiration procedure
  • Procedure: stent retriever procedure
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
381 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Actual Study Start Date :
Oct 10, 2015
Actual Primary Completion Date :
Oct 1, 2016
Actual Study Completion Date :
Feb 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: ADAPT

Procedure: direct aspiration procedure
Revascularization by endovascular thrombectomy using the distal aspiration first pass technique

Active Comparator: Stent Retriever

Procedure: stent retriever procedure
Revascularization by endovascular thrombectomy using a mechanical thrombectomy device

Outcome Measures

Primary Outcome Measures

  1. Complete recanalization percentage [Immediately after the revascularization procedure is completed]

    Proportion of patients in which complete recanalization is achieved as defined by a TICI score equal to 2b or 3

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years with no upper age limit.

  • Cerebral infarction in the anterior circulation

  • Occlusion of the anterior circulation proven by CT angiography or MR angiography

  • With or without previous Intravenous thrombolysis

  • Start of thrombectomy procedure within 6 hours of symptoms onset.

  • Patient expresses verbally his non-opposition to be enrolled in the study ; in case patient cannot communicate, verbal non-opposition is obtained from his close / trusted person

Exclusion Criteria:
  • Absence of indication for thrombectomy

  • Cons-indication for thrombectomy

  • Presence of cerebral infarction of the posterior circulation

  • Occlusion of the cervical carotid artery

  • Allergy to x-ray contrast products

  • Patient was bedridden or using a wheelchair most of the day (pre-event modified Rankin Scale score > 3) prior to stroke

  • Pregnancy or breastfeeding

  • Patient under legal protection

  • No affiliation to health insurance

Secondary exclusion criteria

  • Lack of access route for catheterization

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Pellegrin Bordeaux France
2 Hospices Civils de Lyon Bron France
3 CHU Dupuytren Limoges France
4 CHU Hôpital Gui de Chaulac Montpellier France
5 Hôpital Neurologique Nancy France
6 Hôpital Guillaume et René LAENNEC Nantes France
7 Fondation Ophtalmologique Adolphe de Rothschild Paris France 75019
8 Hôpital Foch Suresnes France

Sponsors and Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

Investigators

  • Principal Investigator: Michel PIOTIN, Fondation ophtalmologique de Rothschild

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier:
NCT02523261
Other Study ID Numbers:
  • MPN_2015_22
First Posted:
Aug 14, 2015
Last Update Posted:
Feb 8, 2018
Last Verified:
Feb 1, 2018
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2018